Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,546 public trials 1,158 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Recruiting

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT06618287

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center Miami, Florida, United States
  • Local Institution - 0065 Iowa City, Iowa, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 65 locations
View Trial Details
Recruiting

Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

NCT07085442

Conditions
Axilla; Breast, Axillary Lymph Nodes Dissection, Axillary Metastases, +10 more
Locations
  • Burnley General Teaching Hospital Burnley, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospitals of Derby and Burton Derby, United Kingdom
  • Gartnavel General Hospital Glasgow, United Kingdom
View Trial Details
Recruiting

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

NCT05573893

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Amberg, Germany
  • Research Site Ansbach, Germany
  • Research Site Apolda, Germany
  • Research Site Aschaffenburg, Germany
View all 109 locations
View Trial Details

Related conditions